Article
Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy.
Frontiers in immunology - 1 Jan 2023
Bi Xiaoyue, Xie Si, Wu Shuling, Cao Weihua, Lin Yanjie, Yang Liu, Jiang Tingting, Deng Wen, Wang Shiyu, Liu Ruyu, Gao Yuanjiao, Shen Ge, Chang Min, Hao Hongxiao, Xu Mengjiao, Chen Xiaoxue, Hu Leiping, Lu Yao, Zhang Lu, Xie Yao, Li Minghui
Abstract excerpt
Background: To investigate the changes of natural killer (NK) cell phenotype in the interferon alpha (IFN-α) treatment of chronic hepatitis B (CHB) and its relationship with clinical indicators. Methods: The CHB patients who did not receive any antiviral treatment were set as initial treatment group and used pegylated interferon alpha (PEG-IFN α). Peripheral blood samples were collected at baseline, 4 weeks, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.